Waffles thank you for the reply, I agree about the support in the 5.00 range,Plenty of Institutions that loaded on the offering will not let it drop below that mark. The low volume is also letting the MM's fade it till we get some news which is close . Brian should release vk5211 data at conference today.
As for Vk2809 and the trials delayed I still wonder if MDGL had the same problem recruiting Patients with their lipid drug in P2 ? and since you mentioned they can pay the patients however much they want they should do it. Its crucial that they keep close to MDGL timeline with their drug now ready for P3.
There are a few Bone Franchises like Hoffman-LaRoche , GlaxoSmithKline with drug Boniva the prescription medication is used to treat osteoporosis and hypercalcemia. They could be a prime Partner for VK5211.
Keep up the great work here Waffles, stay well brother.
News 
Market Data 
Discover 
